| Eyecare Centers Of Aitkin & Mcgregor Optometrists, Pa | |
|
312 Minnesota Ave. N, Aitkin, MN 56431-1414 | |
| (218) 927-3213 | |
| (218) 927-2266 |
| Full Name | Eyecare Centers Of Aitkin & Mcgregor Optometrists, Pa |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 312 Minnesota Ave. N, Aitkin, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104855287 | NPI | - | NPPES |
| 601218300 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2588 (Minnesota) | Primary |
| 152W00000X | Optometrist | 1998 (Minnesota) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Eyecare Centers Of Aitkin & Mcgregor Optometrists, Pa 312 Minnesota Ave N, Suite 1, Aitkin, MN 56431 Ph: (218) 927-3213 | Eyecare Centers Of Aitkin & Mcgregor Optometrists, Pa 312 Minnesota Ave. N, Aitkin, MN 56431-1414 Ph: (218) 927-3213 |
News Archive
Today at the 2005 Experimental Biology Conference, the Dairy Council of California sponsored a thought-provoking symposium titled "Individualized nutrition as a tool to prevent and treat chronic disease."
In his latest Kaiser Health News column, done in collaboration with The New Republic, Jonathan Cohn writes: "Ever since President Barack Obama announced he'd be having a bipartisan meeting to talk about health care reform, Republicans have been denouncing it as a charade.
The results of two studies in the August 15 issue of JAMA report on the psychological status of workers at the Fukushima nuclear power plants in Japan several months after the earthquake and tsunami in March 2011, and the amount of internal radiation exposure among residents of a city north of the power plant that experienced a meltdown.
La Jolla Institute for Allergy & Immunology researchers studying an enzyme believed to play a role in allergy onset, instead have discovered its previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia. Myeloproliferative diseases are a group of disorders characterized by an overproduction of blood cells by the bone marrow and include chronic myeloid leukemia. Lymphoma and leukemia are cancers of the blood.
Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.- Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 174 mg and 348 mg strength bupropion hydrobromide tablets prior to the expiration of patents owned by Biovail. Watson's 174 mg and 348 mg strength bupropion hydrobromide tablet products are generic versions of Biovail's Aplenzin™ ER, which is indicated for major depressive disorder.
› Verified 7 days ago
Dr. Douglas Roland Landsverk, OD Optometrist Medicare: Medicare Enrolled Practice Location: 312 Minnesota Ave N, Aitkin, MN 56431 Phone: 218-927-3213 Fax: 218-927-2266 | |
Dr. Steven Anthony Kinzer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 312 Minnesota Ave N, Aitkin, MN 56431 Phone: 218-927-3213 Fax: 218-927-2266 |